Literature DB >> 16849402

Consequences of fetal exposure to maternal diabetes in offspring.

Lila-Sabrina Fetita1, Eugène Sobngwi, Patricia Serradas, Fabien Calvo, Jean-François Gautier.   

Abstract

CONTEXT: Type 2 diabetes is the result of both genetic and environmental factors. Fetal exposure to maternal diabetes is associated with a higher risk of abnormal glucose homeostasis in offspring beyond that attributable to genetic factors, and therefore, may participate in the excess of maternal transmission of type 2 diabetes. EVIDENCE ACQUISITION: A MEDLINE search covered the period from 1960-2005. EVIDENCE SYNTHESIS: Human studies performed in children and adolescents suggest that offspring who had been exposed to maternal diabetes during fetal life exhibit higher prevalence of impaired glucose tolerance and markers of insulin resistance. Recent studies that directly measured insulin sensitivity and insulin secretion have shown an insulin secretory defect even in the absence of impaired glucose tolerance in adult offspring. In animal models, exposure to a hyperglycemic intrauterine environment also led to the impairment of glucose tolerance in the adult offspring. These metabolic abnormalities were transmitted to the next generations, suggesting that in utero exposure to maternal diabetes has an epigenetic impact. At the cellular level, some findings suggest an impaired pancreatic beta-cell mass and function. Several mechanisms such as defects in pancreatic angiogenesis and innervation, or modification of parental imprinting, may be implicated, acting either independently or in combination.
CONCLUSION: Thus, fetal exposure to maternal diabetes may contribute to the worldwide diabetes epidemic. Public health interventions targeting high-risk populations should focus on long-term follow-up of subjects who have been exposed in utero to a diabetic environment and on a better glycemic control during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849402     DOI: 10.1210/jc.2006-0624

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  84 in total

Review 1.  Diabetes-induced birth defects: what do we know? What can we do?

Authors:  E Albert Reece
Journal:  Curr Diab Rep       Date:  2012-02       Impact factor: 4.810

2.  Developmental programming of the metabolic syndrome - critical windows for intervention.

Authors:  Mark H Vickers
Journal:  World J Diabetes       Date:  2011-09-15

3.  Associations of cord blood leptin and adiponectin with children's cognitive abilities.

Authors:  Nan Li; Tye E Arbuckle; Gina Muckle; Bruce P Lanphear; Michel Boivin; Aimin Chen; Linda Dodds; William D Fraser; Emmanuel Ouellet; Jean R Séguin; Maria P Velez; Kimberly Yolton; Joseph M Braun
Journal:  Psychoneuroendocrinology       Date:  2018-10-25       Impact factor: 4.905

4.  Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care.

Authors:  John L Kitzmiller; Jennifer M Block; Florence M Brown; Patrick M Catalano; Deborah L Conway; Donald R Coustan; Erica P Gunderson; William H Herman; Lisa D Hoffman; Maribeth Inturrisi; Lois B Jovanovic; Siri I Kjos; Robert H Knopp; Martin N Montoro; Edward S Ogata; Pathmaja Paramsothy; Diane M Reader; Barak M Rosenn; Alyce M Thomas; M Sue Kirkman
Journal:  Diabetes Care       Date:  2008-05       Impact factor: 19.112

5.  Mechanisms of developmental programming of the metabolic syndrome and related disorders.

Authors:  Zhong-Cheng Luo; Lin Xiao; Anne-Monique Nuyt
Journal:  World J Diabetes       Date:  2010-07-15

Review 6.  Fetal programming of renal function.

Authors:  Jörg Dötsch; Christian Plank; Kerstin Amann
Journal:  Pediatr Nephrol       Date:  2011-02-07       Impact factor: 3.714

7.  Effects of maternal diabetes and fetal sex on human placenta mitochondrial biogenesis.

Authors:  Shaoning Jiang; April M Teague; Jeanie B Tryggestad; Christopher E Aston; Timothy Lyons; Steven D Chernausek
Journal:  Placenta       Date:  2017-06-06       Impact factor: 3.481

8.  Maternal family history of diabetes is associated with a reduced risk of cardiovascular disease in women with type 2 diabetes: the Fremantle Diabetes Study.

Authors:  David G Bruce; Kylie Van Minnen; Wendy A Davis; Jaspreet Mudhar; Michael Perret; Dayani P Subawickrama; Stephanie Venkitachalam; David Ravine; Timothy M E Davis
Journal:  Diabetes Care       Date:  2010-04-05       Impact factor: 19.112

9.  Dysglycemias in pregnancy: from diagnosis to treatment. Brazilian consensus statement.

Authors:  Carlos Antonio Negrato; Renan M Montenegro; Rosiane Mattar; Lenita Zajdenverg; Rossana P V Francisco; Belmiro Gonçalves Pereira; Mauro Sancovski; Maria Regina Torloni; Sergio A Dib; Celeste E Viggiano; Airton Golbert; Elaine C D Moisés; Maria Isabel Favaro; Iracema M P Calderon; Sonia Fusaro; Valeria D D Piliakas; José Petronio L Dias; Marilia B Gomes; Lois Jovanovic
Journal:  Diabetol Metab Syndr       Date:  2010-04-24       Impact factor: 3.320

10.  Maternal arsenic exposure and impaired glucose tolerance during pregnancy.

Authors:  Adrienne S Ettinger; Ami R Zota; Chitra J Amarasiriwardena; Marianne R Hopkins; Joel Schwartz; Howard Hu; Robert O Wright
Journal:  Environ Health Perspect       Date:  2009-03-11       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.